Antipsychotic Agents: all 1,683 studies that test it
Page 16 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00210691Phase 3
- A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With SchizophreniaCompletedNCT00210548Phase 3
- A Comparison of Two Standard Therapies in the Management of Dementia With AgitationCompletedNCT00208819Phase 4
- Ziprasidone in Children With Autism: A Pilot StudyCompletedNCT00208559Phase 2
- Aripiprazole in Children With Autism: A Pilot StudyCompletedNCT00208533Phase 2
- Geodon (Ziprasidone) for Posttraumatic Stress DisorderCompletedNCT00208208Phase 4
- Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape TraumaCompletedNCT00208182Phase 4
- Abilify Therapy for Reducing Comorbid Substance AbuseCompletedNCT00208169Phase 4
- Seroquel Therapy for Substance Use Disorders Comorbid With SchizophreniaCompletedNCT00208143Phase 4
- Neurobiological and Neurocognitive Disturbances in First-episode SchizophreniaCompletedNCT00207064Not applicable
- Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode SchizophreniaCompletedNCT00206960Not applicable
- Risperidone vs. Paroxetine for Panic AttacksTerminatedNCT00206765Phase 2
- Seroquel in Bipolar Depression Versus LithiumCompletedNCT00206141Phase 3
- Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With SchizophreniaCompletedNCT00206128Phase 3
- Janssen - Glucose Regulation/Risp/OlanzCompletedNCT00205738Not applicable
- Pfizer/IVGTT/Ziprasidone/OlanzapineCompletedNCT00205725Not applicable
- Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality DisorderCompletedNCT00204347Phase 4
- Early Pharmacological and Psychological Intervention for Late Prodromal States of PsychosisCompletedNCT00204061Phase 4
- Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic InmatesTerminatedNCT00203775Not applicable
- Use of Risperidone in ECT for Treatment Resistant DepressionTerminatedNCT00203723Phase 4
- Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use DisorderCompletedNCT00203528Phase 4
- Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesCompletedNCT00202293Phase 4
- Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic IllnessCompletedNCT00199940Phase 4
- Aripiprazole Treatment of Bipolar DepressionCompletedNCT00198198Phase 4
- A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.CompletedNCT00198055Phase 2
- Pilot Study Evaluating the Safety and Efficacy of Open-Label OlanzapineTerminatedNCT00194064Phase 3
- Aripiprazole in Late Life Bipolar DisorderCompletedNCT00194038Phase 4
- Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCompletedNCT00191997Phase 4
- A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational ProgrammeCompletedNCT00191828Phase 4
- Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic TreatmentCompletedNCT00191555Phase 4
- Olanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaCompletedNCT00190892Phase 4
- Clozapine IM and Aggression in Schizophrenic PatientsWithdrawnNCT00189995Phase 3
- A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar DisorderCompletedNCT00188942Phase 4
- Determining the Safety and Effectiveness of Olanzapine in Children and AdolescentsTerminatedNCT00183612Not applicable
- Long-Term Olanzapine Treatment in Children With AutismCompletedNCT00183404Phase 2/3
- Olanzapine in the Treatment of Hair Pulling (Trichotillomania)CompletedNCT00182507Phase 4
- Cognition, Functioning and Quality of LifeCompletedNCT00182442Phase 4
- Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II DisorderCompletedNCT00182013Phase 4
- Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar DisorderCompletedNCT00181935Phase 4
- Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar DisorderCompletedNCT00181922Phase 4
- Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar DisorderCompletedNCT00181779Phase 4
- Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI TreatmentWithdrawnNCT00178854Phase 4
- Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietyCompletedNCT00177008Phase 4
- Treatment of Depression With QuetiapineTerminatedNCT00174603Phase 3
- Treatment of Major Depressive Disorder With Psychotic Features.TerminatedNCT00174590Phase 3
- Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of AntidepressantStatus unknownNCT00174577Phase 3
- Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With RisperidoneCompletedNCT00174200Not applicable
- Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative SymptomsCompletedNCT00169988Not applicable
- Aripiprazole Treatment of the ProdromeTerminatedNCT00169949Not applicable
- Clozapine Versus Haloperidol for Treating the First Episode of SchizophreniaTerminatedNCT00169091Phase 4
- Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant SchizophreniaCompletedNCT00169065Phase 4
- Clozapine Versus Chlorpromazine for Treatment-Unresponsive SchizophreniaTerminatedNCT00169039Phase 4
- Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot StudyCompletedNCT00167817Phase 4
- A Study of Risperidone Monotherapy in Bipolar AnxietyCompletedNCT00167479Phase 4
- Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)CompletedNCT00166595Phase 1/2
- New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant SchizophreniaCompletedNCT00161018Phase 3
- 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)CompletedNCT00159796Phase 3
- 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic PatientsTerminatedNCT00159757Phase 4
- 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)CompletedNCT00159744Phase 3
- One Year Drug Treatment in First-Episode SchizophreniaCompletedNCT00159081Phase 4
- Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality DisorderCompletedNCT00158028Not applicable
- Optimization of Acute Treatment in First Episode SchizophreniaStatus unknownNCT00157378Phase 4
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)CompletedNCT00156117Phase 3
- Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)CompletedNCT00156104Phase 3
- Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)CompletedNCT00156091Phase 3
- A Long Term Study of Clozapine in Patients With Treatment-resistant SchizophreniaCompletedNCT00154258Phase 2
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)CompletedNCT00151424Phase 3
- Energy Homeostasis Under Treatment With Atypical AntipsychoticsCompletedNCT00148564Phase 4
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in SchizophreniaCompletedNCT00148083Phase 3
- Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)CompletedNCT00147394Phase 1
- Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind StudyCompletedNCT00145444Phase 3
- Mozart Relapse StudyCompletedNCT00143351Phase 3
- 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)CompletedNCT00143182Phase 3
- Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective DisorderCompletedNCT00137020Phase 4
- IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)CompletedNCT00136994Phase 3
- Civilian Post-Traumatic Stress Disorder Risperidone Clinical TrialCompletedNCT00133822Phase 1/2
- SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I PatientsCompletedNCT00126009Phase 2
- Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced CancerTerminatedNCT00124930Phase 3
- Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.CompletedNCT00124059Phase 3
- Loxapine and Weaning From VentilatorCompletedNCT00122733Not applicable
- Quetiapine Treatment for Symptoms Associated With Borderline Personality DisorderCompletedNCT00122070Phase 3
- A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With SchizophreniaCompletedNCT00119756Phase 3
- Seroquel in Bipolar Depression Versus SSRICompletedNCT00119652Phase 3
- Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy AdultsCompletedNCT00118924Phase 1
- Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00116259Not applicable
- Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar DisorderCompletedNCT00114686Phase 3
- Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCompletedNCT00113594Phase 3
- A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.CompletedNCT00111189Phase 3
- The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
- Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00107731Phase 3
- Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia PatientsCompletedNCT00105326Phase 2
- Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00103571Phase 4
- Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With SchizophreniaCompletedNCT00101634Phase 3
- Aripiprazole Oral Acceptability TrialCompletedNCT00101569Phase 3
- Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00100776Phase 4
- Study of Aripiprazole in Patients With Acute Bipolar ManiaCompletedNCT00097266Phase 3
- Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I OutpatientsCompletedNCT00097032Phase 3
- The MIND Study: Modifying the INcidence of DeliriumCompletedNCT00096863Phase 2
- A Study of Adjunctive Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00095823Phase 3
- Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseCompletedNCT00095810Phase 4